Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience

People living with HIV (PLWH) are at high risk of herpes zoster (HZ). The recombinant anti-HZ vaccine (RZV), approved by European Medicines Agency (EMA) in 2018, has been shown to be effective and safe in PLWH. This study aims to describe the implementation of RZV in our center. Prospective cohort s...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Benedetta Trentacapilli, Angelo Roberto Raccagni, Sara Diotallevi, Silvia Nozza, Riccardo Lolatto, Anna Carole D’Amelio, Gaia Catalano, Giacomo Ponta, Vincenzo Spagnuolo, Massimo Cernuschi, Nicola Gianotti, Antonella Castagna, Diana Canetti
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-02-01
Sarja:	Frontiers in Virology
Aiheet:	herpes zoster proactive vaccination HIV implementation prioritization
Linkit:	https://www.frontiersin.org/articles/10.3389/fviro.2025.1537821/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!